U.S. RESEARCH ROUNDUP-Gemphire Therapeutics, Rollins, Viasat

Establishment Labs Holdings

13/08/2018 08:24

Aug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Gemphire Therapeutics Inc, Rollins Inc and Viasat
Inc, on Monday.   
   
  HIGHLIGHTS
    *  Gemphire Therapeutics Inc  GEMP.O : Jefferies cuts to hold from buy
    *  Rollins Inc  ROL.N : Stifel raises price target to $55 from $50
    *  Viasat Inc  VSAT.O : Barclays cuts price target to $50 from $60     
      
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
      
     *  Aimmune Therapeutics Inc  AIMT.O : Credit Suisse cuts price target to $40 from $47
     *  Alder Biopharmaceuticals Inc  ALDR.O : Credit Suisse raises target to $19 from $16
     *  Alnylam Pharmaceuticals Inc  ALNY.O : Cowen and Company cuts target to $147 from $157
     *  Antero Resources Corp  AR.N : Susquehanna cuts price target to $27 from $28
     *  Boston Private Financial Holdings BPFH.O :SunTrust Robinson cuts target to $15 from $18
     *  California Resources Corp  CRC.N : Susquehanna cuts price target to $40 from $42
     *  Cimarex Energy Co  XEC.N : Susquehanna cuts price target to $100 from $113
     *  CNX Resources Corp  CNX.N : Susquehanna cuts price target to $18 from $19
     *  Continental Resources Inc  CLR.N : Susquehanna maintains price target of $67 
     *  Deere & Co  DE.N : JP Morgan cuts price target to $145 from $154
     *  Digital Realty Trust Inc  DLR.N : RBC raises price target to $131 from $128
     *  EOG Resources Inc  EOG.N : Susquehanna raises price target to $138 from $136
     *  Establishment Labs Holdings Inc  ESTA.O : Jefferies starts with buy rating; target $35
     *  Flowserve Corp  FLS.N : Stifel raises price target to $47 from $43
     *  Gemphire Therapeutics Inc  GEMP.O : Jefferies cuts price target to $2 from $12
     *  Gemphire Therapeutics Inc  GEMP.O : Jefferies cuts to hold from buy
     *  Healthcare Realty Trust Inc  HR.N : Jefferies raises price target to $32 from $29
     *  Healthcare Trust of America Inc  HTA.N : Jefferies raises price target to $34 from $30
     *  Intel Corp  INTC.O : Cowen and Company cuts price target to $49 from $52
     *  Orion Engineered Carbons SA  OEC.N : Jefferies raises price target to $41 from $38
     *  Physicians Realty Trust  DOC.N : Jefferies raises price target to $18 from $16
     *  Rollins Inc  ROL.N : Stifel raises price target to $55 from $50
     *  Rubius Therapeutics Inc  RUBY.O : Jefferies starts with buy rating; price target $40
     *  Sabra Health Care REIT SBRA.O :Capital One Securities raises target to $23.50 from $20
     *  Sierra Oncology Inc  SRRA.O : Jefferies cuts price target to $4.29 from $4.48
     *  Tapestry Inc  TPR.N : Canaccord Genuity cuts price target to $55 from $58
     *  TransDigm Group Inc  TDG.N : Barclays raises price target to $400 from $382
     *  Viasat Inc  VSAT.O : Barclays cuts price target to $50 from $60
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))